ABSTRACT
Cancer is a global problem. In 2019, there were 606,880 cancer deaths and 1,762,450 new cases, according to the National Center for Health Statistics (NCCS). To address this, research is being conducted globally. Phytochemical-based cancer treatments have gained favour in recent years. Plants create phytochemicals as a form of protection. These can also be used to treat a variety of serious conditions, including cancer. In this investigation, we looked at how Careya arborea, Ficus religiosa, and Amorphophallus campanulatus affected the growth of A549 human lung cancer cells. The MTT test is used to measure cell viability. Cell lines for human lung cancer were purchased from NCCS in Pune. These cells were made using 4.4 grams of glucose, L-glutamine, and sodium pyruvate. Human fetal blood serum (FBS) nourished cells with growth factors. When testing the viability of cells after exposing them to plant extracts in methanol and distilled water, we focused on a few specific plants. Between control and plant extract-treated cells, we found differences.
